Natco Pharma Quarterly Results for Trading Insights
NATCOPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹518 Cr
QSept 2025
Natco Pharma Quarterly Results Key Highlights
- Revenue of ₹1,463 Cr in Sept 2025 (+13.7% vs Mar 2025, +2.0% vs Sept 2024)
- Net Profit of ₹518 Cr in Sept 2025 (+27.6% vs Mar 2025, -23.5% vs Sept 2024)
- EBITDA of ₹679 Cr in Sept 2025 (+10.6% vs Mar 2025)
- Operating Margin of 42.0% in Sept 2025 (-3.0pp vs Mar 2025)
- Earnings Per Share of ₹28.94 in Sept 2025 (+27.5% vs Mar 2025)
Natco Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,463 | 1,287 | 1,391 | 1,435 | 1,110 | 13.7% | 2.0% |
| Net Profit (₹ Cr) | 518 | 406 | 480 | 677 | 386 | - | - |
| EBITDA (₹ Cr) | 679 | 614 | 633 | 868 | 539 | - | - |
| EPS (₹) | 28.94 | 22.70 | 26.84 | 37.81 | 21.56 | - | - |
| Operating Margin (%) | 42.0% | 45.0% | 43.0% | 59.0% | 47.0% | - | - |
Natco Pharma Share Price Trend Around Quarterly Results
Visualize Natco Pharma's 1-year price movement across quarterly results — ideal for logging trades in Natco Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Natco Pharma
Additional stock information and data for NATCOPHARM
Revenue Trend (₹ Cr)
Sept 2024
1,435
Jun 2025
1,391
Mar 2025
1,287
Sept 2025
1,463
Net Profit Trend (₹ Cr)
Sept 2024
677
Jun 2025
480
Mar 2025
406
Sept 2025
518
Operating Margin Trend (%)
Sept 2024
59.0%
Jun 2025
43.0%
Mar 2025
45.0%
Sept 2025
42.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Natco Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores